keyword
MENU ▼
Read by QxMD icon Read
search

Sertralina

keyword
https://www.readbyqxmd.com/read/30106883/efficacy-of-sertraline-in-patients-with-major-depressive-disorder-naive-to-selective-serotonin-reuptake-inhibitors-a-10-week-randomized-multicenter-placebo-controlled-double-blind-academic-clinical-trial
#1
Roselin Valle-Cabrera, Yudexi Mendoza-Rodríguez, Maytee Robaina-García, Javier Ballesteros, Juan Rafael Cordero-Jiménez, Nadia B Espinosa-Rodríguez, Yenia Sotolongo-Garcia, Bianca Lauria-Horner
PURPOSE: The aim of this study was to assess the efficacy and safety of sertraline compared with placebo in a good clinical practice trial conducted with major depressive disorder patients naive to selective serotonin reuptake inhibitors. METHODS: This was a 10-week randomized, multicenter, placebo-controlled, double blind, superiority trial. Adult patients diagnosed with major depressive disorder (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria), total score of 19 to 36 in the 17-item Hamilton Depression Rating Scale (HAMD-17), were randomly allocated to sertraline (n = 39) or placebo (n = 38)...
October 2018: Journal of Clinical Psychopharmacology
https://www.readbyqxmd.com/read/28692075/late-onset-clozapine-induced-sierositis-the-case-of-ms-c
#2
Giuseppina Trincas, Donatella Lampugnani, Stefano Beretta, Cesare Maria Cornaggia, Agata Distefano, Massimiliano Beghi
INTRODUCTION: Polisierositis is a rare but not negligible adverse event of a therapy with clozapine, that occurs usually during the titration phase of clozapine or just after the reachment of the plateau, and politherapy increases the incidence rate. CASE REPORT: Ms. C. is a 42 years old smoker woman who suffers from a schizophrenia associated to a borderline personality disorder. In 2007 a therapy with clozapine was introduced with good tolerance and efficacy on her symptoms for a long period...
May 2017: Rivista di Psichiatria
https://www.readbyqxmd.com/read/17345878/-antidepressant-drugs-and-breastfeeding
#3
REVIEW
Cesario Bellantuono, Giovanni Migliarese, Francesca Maggioni, Giuseppe Imperadore
The post-partum period, as well as pregnancy, is associated with an increased risk of anxiety and/or affective disorders. Postnatal depression, frequently in co-morbidity with anxiety symptoms, is recognised as the most frequent form of maternal morbidity after delivery, with a prevalence rate estimated between 5% to 15%. Among antidepressant drugs, the SSRIs are considered the drugs of choice in the treatment of post-partum affective disorders, particularly in the major depression. It is, thus, crucial from a clinical standpoint to establish, in the newborn whose mother needs to be treated with an SSRI, the safety profile of these drugs during breastfeeding...
January 2007: Recenti Progressi in Medicina
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"